D T Klink R M van Elburg M W J Schreurs G T J van Well
10.1155/2008/271363
Clin Dev Immunol
2008;2008:271363.
CC BY
https://pubmed.ncbi.nlm.nih.gov/18596903/
Antibodies, Monoclonal / therapeutic use B-Lymphocytes / immunology Immunologic Factors / therapeutic use Pregnancy Complications, Hematologic / drug therapy Purpura, Thrombocytopenic, Idiopathic / drug therapy
Antibodies, Monoclonal / therapeutic use B-Lymphocytes / immunology Immunologic Factors / therapeutic use Pregnancy Complications, Hematologic / drug therapy Purpura, Thrombocytopenic, Idiopathic / drug therapy Case Reports Adult Antibodies, Monoclonal / administration & dosage Antibodies, Monoclonal / adverse effects Antibodies, Monoclonal / immunology Antibodies, Monoclonal, Murine-Derived Antigens, CD20 / immunology B-Lymphocytes / metabolism Female Humans Immunologic Factors / administration & dosage Immunologic Factors / adverse effects Immunologic Factors / immunology Infant, Newborn Pregnancy Pregnancy Complications, Hematologic / immunology Pregnancy Trimester, Third Purpura, Thrombocytopenic, Idiopathic / immunology Rituximab Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antigens, CD20 Immunologic Factors Rituximab
PMC2438602
18596903
Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development
2008